The Patent Finder

Tetra Discovery Partners, LLC

10 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 30, 2027
    The maintenance fee for Heteroaryl inhibitors of PDE4 (US 10,364,258) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Heteroaryl inhibitors of PDE4 (US 11,767,334) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
  • 1 fee due Jun 29, 2027
    The maintenance fee for Heteroaryl inhibitors of PDE4 (US 9,221,843) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
  • 1 fee due Oct 21, 2027
    The maintenance fee for Heteroaryl inhibitors of PDE4 (US 10,626,129) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 9,221,843Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,777,024Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,093,686Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,364,258Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,626,129Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,401,286Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,767,334Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,264,169Heteroaryl inhibitors of PDE4
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,028,050Salts and polymorphs of a PDE4 inhibitor
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,104,660PDE4D inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 10: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited